We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
The CMA investigated and cleared the completed acquisition by Energystore Limited of WarmFill Ltd, Warmwall Limited and related assets by Energystore Limited.
Pfizer Limited has informed us that the packs for the affected batches below have not been packaged with the current version of the Patient Information Leaflet (PIL) containing updated storage instructions of the infusion solution in section 5.
The CMA has fined firms over £35 million for an illegal arrangement in the supply of important NHS prescription anti-nausea tablets.
The CMA has opened an investigation into suspected anti-competitive practices in the supply of drugs used to treat bipolar disorder.
Employment Tribunal decision.
The CMA is consulting on proposed commitments from Essential Pharma to keep a key bipolar drug on the market, and ensure it is affordable to the NHS.
A Cumbrian collaboration has manufactured a world-first nuclear space saver.
Bayer is recalling the listed batches due to reduced potency of the active ingredient
(Accord Healthcare Limited) Recipients should quarantine any remaining stock and return it to supplier for credit - class 2 action within 48 hours. (EL (13)A/32)
CEO Andrea Coscelli delivers a speech at the GCR Live TMT event.
(AstraZeneca UK Limited) This presentation cannot be administered by intra-articular means as it states on the carton and ampoule label on all batches released since December 2012 (EL(15)A/09)
Licensed doses and differences in potency between different inhaled corticosteroids; advice for use with spacer device.
Medicines have been taken out of the regulated medicines’ supply chain during distribution. The products have been parallel imported into the UK by B & S Healthcare from Italy and have been re-labelled in B & S Healthcare livery.
Closed Competition Commission (CC) merger inquiry.
OFT closed case: Completed acquisition by Coloplast A/S of the Urology Business of Mentor Corporation.
Clariant’s anticipated acquisition of Kilfrost’s de-/anti-icing fluids business could be blocked by the CMA.
Clariant’s anticipated acquisition of Kilfrost’s de-/anti-icing fluids business faces being referred for an in-depth investigation by the CMA.
The CMA has found that Sonoco Products Company’s acquisition of Weidenhammer Packaging Group GmbH gives rise to a realistic prospect of a substantial lessening of competition and will be referred for an in-depth phase 2 investigation unless acceptable undertakings are...
The CMA has provisionally concluded that Tesco’s purchase of Booker does not raise competition concerns.
Upper Tribunal Tax and Chancery decision of Mr Justice Henderson and Judge Sinfield on 19 July 2016.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).